Document Detail


Inhaled iloprost for therapy in pulmonary arterial hypertension.
MedLine Citation:
PMID:  21510725     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Iloprost (Ventavis(®), Bayer Schering Pharma, Germany) is a synthetic prostacyclin that is used in its inhalative form for the therapy of pulmonary arterial hypertension. Long-term therapy can increase exercise capacity and quality of life. The use of modern nebulizers especially designed for the administration of iloprost guarantees the pulmonary deposition of the required doses and systematically minimizes side effects. Regarding existing data, inhalative iloprost acts in effective and safe combination with other classes of medication; indeed, such combination therapy is frequently necessary in pulmonary arterial hypertension.
Authors:
Ralf Ewert; Sven Gläser; Tom Bollmann; Christoph Schäper
Related Documents :
105585 - Calibrated leak balloon microcatheter: a device for arterial exploration and occlusive ...
21326515 - Uterine artery embolization: a safe and effective, minimally invasive, uterine-sparing ...
2144535 - Aneurysm mimicking intracranial growth of optic nerve sheath meningioma.
15633985 - Estimating the annual rate of de novo multiple aneurysms: three statistical approaches.
18202905 - Experience of robotic catheter ablation in humans using a novel remotely steerable cath...
16799315 - A hemodynamic study of the effects of arterial anastomoses with interrupted simple vers...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of respiratory medicine     Volume:  5     ISSN:  1747-6356     ISO Abbreviation:  Expert Rev Respir Med     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-04-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278196     Medline TA:  Expert Rev Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  145-52     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Ernst-Moritz-Arndt University, Greifswald, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Xanthine oxidase inhibitors: a patent survey.
Next Document:  Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.